It is well established that approximately 25% of PTC cases coexist with Hashimoto’s thyroiditis, a correlation supported by shared biomarkers, genetic mutations, and immune-mediated pathways involving Cd3+, Cd4+, and Th17 cells [24]. The gene discussed is CD4; the disease is Hashimoto thyroiditis.